Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment

Abstract

SCD mortality in Belgium is low with no increase observed in young adults. Patients treated with hydroxyurea demonstrate a significant benefit in survival when compared to those without DMT or transplanted.